Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
McKinsey

Last Updated: December 8, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR RIVASTIGMINE TARTRATE

➤ Subscribe for complete access

« Back to Dashboard

All Clinical Trials for rivastigmine tartrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01084135 ↗ Rivastigmine Study in Adolescents With Down Syndrome Completed Hugo W. Moser Research Institute at Kennedy Krieger, Inc. Phase 1/Phase 2 2009-11-01 The purpose of this study is to determine if short term use of rivastigmine can improve functional abilities (for example, language, memory, and executive function) in adolescents with Down syndrome.
NCT01084135 ↗ Rivastigmine Study in Adolescents With Down Syndrome Completed Taishoff Family Foundation Phase 1/Phase 2 2009-11-01 The purpose of this study is to determine if short term use of rivastigmine can improve functional abilities (for example, language, memory, and executive function) in adolescents with Down syndrome.
NCT01084135 ↗ Rivastigmine Study in Adolescents With Down Syndrome Completed Duke University Phase 1/Phase 2 2009-11-01 The purpose of this study is to determine if short term use of rivastigmine can improve functional abilities (for example, language, memory, and executive function) in adolescents with Down syndrome.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for rivastigmine tartrate

Condition Name

Condition Name for rivastigmine tartrate
Intervention Trials
Down Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for rivastigmine tartrate
Intervention Trials
Syndrome 1
Down Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for rivastigmine tartrate

Trials by Country

Trials by Country for rivastigmine tartrate
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for rivastigmine tartrate
Location Trials
North Carolina 1
Maryland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for rivastigmine tartrate

Clinical Trial Phase

Clinical Trial Phase for rivastigmine tartrate
Clinical Trial Phase Trials
Phase 1/Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for rivastigmine tartrate
Clinical Trial Phase Trials
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for rivastigmine tartrate

Sponsor Name

Sponsor Name for rivastigmine tartrate
Sponsor Trials
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. 1
Taishoff Family Foundation 1
Duke University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for rivastigmine tartrate
Sponsor Trials
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Baxter
McKesson
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.